World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
83
Citations
35549
World Ranking
958
National Ranking
87

Medicine

D-Index
86
Citations
36815
World Ranking
13913
National Ranking
1285

Paul T. Heath publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Paul T. Heath sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 392 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Paul T. Heath D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Paul T. Heath sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 83 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Paul T. Heath is affiliated with St George's, University of London in the United Kingdom and has contributed extensively to the field of Medicine, particularly focusing on Epidemiology, Infectious Diseases, Public Health, Microbiology, and related subfields.

The scientist's research covers key topics such as:

  • Neonatal and Maternal Infections
  • Pneumonia and Respiratory Infections
  • SARS-CoV-2 and COVID-19 Research
  • Bacterial Infections and Vaccines
  • Vaccine Coverage and Hesitancy
  • Streptococcal Infections and Treatments
  • COVID-19 Impact on Reproduction

Among their recent papers are the following:

  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK, 2020, The Lancet
  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial, 2020, The Lancet
  • Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection, 2021, Nature Medicine
  • Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial, 2021, The Lancet
  • Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial, 2021, The Lancet

Frequent co-authors collaborating with Paul T. Heath include:

  • Kirsty Le Doaré
  • Asma Khalil
  • Matthew D. Snape
  • Christine E. Jones
  • Saul N. Faust

The scientist regularly publishes in several journals, with multiple contributions to these venues:

  • Open Forum Infectious Diseases
  • The Pediatric Infectious Disease Journal
  • Vaccine
  • The Lancet
  • Journal of Infection

Best Publications

  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

    M Voysey;Clemens Sac.;S A Madhi;L Y Weckx

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

    P M Folegatti;K J Ewer;P K Aley;B Angus

  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

    M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  • Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

    Pedro M Folegatti;Katie J Ewer;Parvinder K Aley;Brian Angus

  • Neonatal sepsis: an international perspective

    S Vergnano;M Sharland;P Kazembe;C Mwansambo

  • Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis.

    Karen M Edmond;Christina Kortsalioudaki;Susana Scott;Stephanie J Schrag

  • Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.

    Katherine R W Emary;Tanya Golubchik;Parvinder K Aley;Cristina V Ariani

  • Neonatal infections in England: the NeonIN surveillance network

    Stefania Vergnano;Esse Menson;Nigel Kennea;Nick Embleton

  • Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.

    Paul T. Heath;Eva P. Galiza;David N. Baxter;Marta Boffito

  • Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children.

    Anna C. Seale;Fiorella Bianchi-Jassir;Neal J. Russell;Maya Kohli-Lynch

  • Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses.

    Jennifer Hall;Nadine Hack Adams;Linda Bartlett;Anna C Seale;Anna C Seale

  • Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.

    Xinxue Liu;Robert H Shaw;Arabella S V Stuart;Melanie Greenland

  • Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses.

    Lola Madrid;Lola Madrid;Anna C. Seale;Anna C. Seale;Maya Kohli-Lynch;Maya Kohli-Lynch;Karen M. Edmond

  • An overview of global GBS epidemiology.

    Kirsty Le Doare;Paul T. Heath

  • Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

    Shabir A Madhi;Fernando P Polack;Pedro A Piedra;Flor M Munoz

  • COVID-19 Vaccination During Pregnancy: Coverage and Safety.

    Helena Blakeway;Smriti Prasad;Erkan Kalafat;Paul T. Heath

  • SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes.

    Asma Khalil;Asma Khalil;Erkan Kalafat;Erkan Kalafat;Can Benlioglu;Pat O'Brien;Pat O'Brien

  • X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management, and outcome of the disease

    Claire Booth;Kimberly C. Gilmour;Paul Veys;Andrew R. Gennery

  • Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

    Unknown

  • Group B streptococcal disease in UK and Irish infants younger than 90 days

    Paul T. Heath;Gail Balfour;Abbie M. Weisner;Androulla Efstratiou

  • Severe and unrecognised: pertussis in UK infants.

    N S Crowcroft;R Booy;T Harrison;L Spicer

  • Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (preprint)

    Voysey, Merryn, Costa Clemens, Sue Ann, Madhi, Shabir A.;Weckx, Lily Yin, Folegatti, Pedro M.;Parvinder K. Aley;Angus, Brian John, Baillie, Vicky, Barnabas, Shaun L.

  • Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant

    Seth Toback;Paul T. Heath;Eva P. Galiza;David Baxter

Frequent Co-Authors

Shamez N. Ladhani
Shamez N. Ladhani UK Health Security Agency
Andrew J. Pollard
Andrew J. Pollard University of Oxford
Mike Sharland
Mike Sharland St George's, University of London
Adam Finn
Adam Finn University of Bristol
Matthew D. Snape
Matthew D. Snape University of Oxford
Saul N. Faust
Saul N. Faust University Hospital Southampton NHS Foundation Trust
Shabir A. Madhi
Shabir A. Madhi University of the Witwatersrand
Mary Ramsay
Mary Ramsay UK Health Security Agency
Mary P. E. Slack
Mary P. E. Slack Griffith University
Asma Khalil
Asma Khalil St George's, University of London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to various allied health and science careers that can also be explored through online education. For those interested in healthcare administration, some of the fastest online medical billing and coding certificate programs offer a quick path to entering the medical billing sector, complementing microbiology knowledge with essential administrative skills.

If you are looking for advanced options, there are several medical degrees online that pay well. These programs allow microbiologists to pivot into clinical roles or healthcare management while benefiting from the flexibility of remote learning.

Additionally, those interested in public health can explore online MPH programs easy to get into. These degrees expand career options into epidemiology, health education, and global health initiatives, fields closely aligned with microbiology’s focus on disease and prevention.

Career pathways in child development and support services also intersect with microbiology through health science applications. For example, understanding health impacts can enhance roles such as a child life specialist. Exploring the child specialist salary and career requirements can provide valuable insights for microbiology graduates considering this pathway.

Best Scientists Citing Paul T. Heath

Trending Scientists

Recently Published Articles